Rapid Medical Announces First Stroke Patient Treated With TIGERTRIEVER

The controllable, fully visible TIGERTRIEVER is designed to treat ischemic stroke patients

Jan 19, 2016, 08:00 ET from Rapid Medical

YOKNEAM, Israel, January 19, 2016 /PRNewswire/ --

Rapid Medical, a company focused on the development of neurovascular interventional devices, announced today that the first patient has been treated with its CE marked TIGERTRIEVER revascularization device. The TIGERTRIEVER uses Rapid Medical's unique and proprietary technology enabling the first fully-visible, controllable stentriever that can be adjusted by the physician to perfectly fit the dimensions of blocked blood vessels that cause acute ischemic stroke.

"I am very pleased with the results and performance of the device," said Prof. René Chapot, MD, Head of the Neuroradiology Department at Alfried Krupp Hospital in Essen, Germany. "The TIGERTRIEVER's unique braiding and adjustability allowed me to safely secure the blood clot during its retrieval and achieve complete recanalization in one attempt. The TIGERTRIEVER has vast clinical potential and I am very happy to be the first physician using this breakthrough device."

The TIGERTRIEVER makes use of Rapid Medical's proprietary technology platform based on more than 7 years of experience in controllable and visible advanced braided stent design to accomplish both excellent continuous adjustability and high radial force.

"Our mission is to build safe and effective neurovascular medical devices that are beneficial to patients and meet physicians' needs," said Ronen Eckhouse, CEO. "We are very excited with the clinical feedback we are receiving for the TIGERTRIEVER and with these initial results. We believe the TIGERTRIEVER is poised to become the leading device for ischemic stroke intervention."

Rapid Medical plans to launch the TIGERTRIEVER in Europe during Q2 2016.

About Rapid Medical 

Rapid Medical is developing game-changing devices for endovascular treatments. Rapid Medical is the maker of Comaneci, the first-ever controllable aneurysm neck-bridging device, and Pele, a large lumen distal access catheter. TIGERTRIEVER, Comaneci, and Pele are CE marked for use in Europe. More information is available at http://www.rapid-medical.com

Ronen Eckhouse, CEO
Rapid Medical

SOURCE Rapid Medical